Resonant Capital Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,073
Closed -$293K 262
2022
Q3
$293K Buy
4,073
+159
+4% +$14.3K 0.04% 190
2022
Q2
$354K Buy
3,914
+79
+2% +$8.18K 0.06% 178
2022
Q1
$427K Buy
3,835
+2
+0.1% +$234 0.06% 150
2021
Q4
$466K Buy
3,833
+430
+13% +$47.8K 0.07% 145
2021
Q3
$343K Buy
3,403
+667
+24% +$73.6K 0.06% 156
2021
Q2
$321K Buy
2,736
+11
+0.4% +$1.32K 0.06% 152
2021
Q1
$302K Buy
2,725
+110
+4% +$11.9K 0.06% 149
2020
Q4
$264K Buy
+2,615
New +$242K 0.06% 153

Other funds holding EMN

Resonant Capital Advisors's EMN Position: Q4 2022 in Review

Resonant Capital Advisors sold out of Eastman Chemical (EMN) in Q4 2022, closing a stake of 4,073 shares — an estimated $293K sold.

Resonant Capital Advisors first reported a position in EMN in Q4 2020 and held it in 8 quarters. The position peaked at $466K in Q4 2021. 706 funds tracked by Wall St. Rank hold EMN as of Q4 2022.

  • Resonant Capital Advisors reported no remaining Eastman Chemical position as of Q4 2022 after selling out during the quarter.
  • Resonant Capital Advisors sold 4,073 Eastman Chemical shares in Q4 2022, an estimated $293K.
  • Resonant Capital Advisors first reported a position in Eastman Chemical in Q4 2020 and held it in 8 quarters.
  • Resonant Capital Advisors's Eastman Chemical position peaked at $466K in Q4 2021.
  • 706 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2022.

Based on Resonant Capital Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.